The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

Author:

Bhardwaj AnjanaORCID,Singh Harpreet,Trinidad Celestine Marie,Albarracin Constance T.,Hunt Kelly K.,Bedrosian Isabelle

Funder

Duncan Family Institute for Cancer Prevention and Risk Assessment

Hamill Foundation

Publisher

Springer Science and Business Media LLC

Reference39 articles.

1. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol. 1996;148(1):313–9 Available from: https://www.ncbi.nlm.nih.gov/pubmed/8546221 PMID:8546221 .

2. Miller FR, Santner SJ, Tait L, Dawson PJ. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst. 2000;92(14):1185–6 Available from: https://www.ncbi.nlm.nih.gov/pubmed/10904098 https://doi.org/10.1093/jnci/92.14.1185a PMID:10904098 .

3. Kim SH, Miller FR, Tait L, Zheng J, Novak RF. Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression. Int J Cancer. 2009;124(12):2813–28 Available from: https://www.ncbi.nlm.nih.gov/pubmed/19291795 https://doi.org/10.1002/ijc.24278 PMID:19291795 .

4. Bhardwaj A, Singh H, Rajapakshe K, Tachibana K, Ganesan N, Pan Y, et al. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer. Oncotarget. 2017;8(12):19645–60 Available from: http://www.ncbi.nlm.nih.gov/pubmed/28160548 https://doi.org/10.18632/oncotarget.14902 PMID:28160548 .

5. Cloonan N, Wani S, Xu Q, Gu J, Lea K, Heater S, et al. MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol. 2011;12(12):R126 Available from: https://www.ncbi.nlm.nih.gov/pubmed/22208850 https://doi.org/10.1186/gb-2011-12-12-r126 PMID:22208850 .

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3